A Biobank for Bipolar Disorder, by Mayo Clinic Individualized Medicine

Overview

About this study

The purpose of this biobank is to develop a research resource for bipolar disorder. Patients, and close genetic relatives, will provide samples of blood, complete interviews, complete health questionnaires, and allow access to medical records. Participants will also agree to be followed into the future by linking to medical records, along with occasional follow-up health surveys or collection of additional biologic specimens. The biobank serves as a source for researchers instead of having to look for volunteers for each new project.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Age 13-80 years
Male or female
Any race or ethnicity
Diagnosis of bipolar I or II disorder, or BP schizoaffective(DSM-IV criteria, SCID- confirmed)
- Use the SCID DSM-IV or SCID DSM-V assessment
- A repeat SCID assessment is not needed if has already completed the DSM-IV or DSM-V SCID within one year of enrollment
Family members defined as first degree relatives into the study that do or do not have bipolar disorder. First degree relatives are defined as parents, offspring, and siblings of subject enrolled in the Bipolar Biobank

Exclusion Criteria

Inability to speak English
Inability or unwilling to provide consent
Unwilling to consent to providing biospecimens to be stored in the biobank for an indefinite amount of time and to be used in future research studies of as yet unknown design
Actively psychotic or suicidal
Cognitive concerns

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Mark Frye, M.D.	Closed for enrollment	Contact information: Cynthia Stoppel CCRP (507) 284-5914 Stoppel.Cynthia@mayo.edu
Jacksonville, Fla. Mayo Clinic principal investigator Teresa Rummans, M.D.	Closed for enrollment	Contact information: Adriana Vasquez M.D. (904) 953-6193 vasquez.adriana@mayo.edu
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Mark Frye, M.D.	Closed for enrollment	Contact information: Lois Krahn M.D. (480) 301-8297 krahn.lois@mayo.edu
Austin, Minn. Mayo Clinic principal investigator Mark Frye, M.D.	Closed for enrollment	Contact information: Mark Frye M.D. (507) 255-9412 MFrye@mayo.edu
Eau Claire, Wis. Mayo Clinic principal investigator Mark Frye, M.D.	Closed for enrollment	Contact information: Mark Frye M.D. (507) 255-9412 MFrye@mayo.edu

Mark Frye M.D.

(507) 255-9412

MFrye@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials